Intrathecal clinical trials

Explore recruiting intrathecal clinical trials.

Recruiting intrathecal studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Intrathecal trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Risk-benefit analysis of intrathecal morphine administration to patients undergoing surgical treatment of proximal femoral fracture (monocentric, single-blinded, randomized clinical study compared to standard treatment)

Czechia

Therapeutic confirmatory (Phase III) EU CTIS Study details

Intrathecal contrast-enhanced MRI for investigation of cerebrospinal fluid transportation

Sweden

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase IIb, Non-Profit, Open-label Trial for the Intrathecal Administration of AAV9/AP4M1 for Hereditary Spastic Paraplegia Type 50 (SPG50).

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Intrathecal application of PD-1 antibody in metastatic solid tumors with leptomeningeal disease

Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Multicentre, open-label, randomized controlled non-inferiority trial comparing single dose intrathecal morphine and continuous thoracic epidural analgesia for multimodal analgesia in open colorectal surgery: the ColoREDIT protocol

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

ION356-CS1: A Phase 1b Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Intrathecally Administered ION356 in Patients with Pelizaeus-Merzbacher Disease

Netherlands, Germany, France

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Intrathecal trials by city

Intrathecal in Toronto Intrathecal in Vancouver Intrathecal in Montreal Intrathecal in Calgary Intrathecal in Edmonton Intrathecal in Ottawa Intrathecal in Winnipeg Intrathecal in Quebec City Intrathecal in Hamilton Intrathecal in Kitchener Intrathecal in London Intrathecal in Halifax Intrathecal in New York Intrathecal in Los Angeles Intrathecal in Chicago Intrathecal in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease